Stay updated on Influenza Virus Challenge Trial for Monoclonal Antibody
Sign up to get notified when there's something new on the Influenza Virus Challenge Trial for Monoclonal Antibody page.

Latest updates to the Influenza Virus Challenge Trial for Monoclonal Antibody page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe additions now explicitly state that PubMed publications are automatically filled from PubMed and include the revision tag v3.3.2. The deletions now use updated wording indicating PubMed publications originate from PubMed and include the revision tag v3.2.0.SummaryDifference0.1%

- Check19 days agoChange DetectedThe government funding status notice on the page has been removed. This notice previously informed users about potential delays and information updates related to funding.SummaryDifference0.4%

- Check34 days agoChange DetectedAdded London, United Kingdom as a study location and updated the recruitment status.SummaryDifference0.3%

- Check62 days agoChange DetectedThe page now includes a government-funding and operating-status notice and marks a new version (v3.2.0), replacing the previous v3.1.0.SummaryDifference4%

- Check69 days agoChange Detected- Added new chemical categories and contact numbers; updated revision to v3.1.0. - Removed several drug-safety and saline-related terms and older revision v3.0.2.SummaryDifference1%

- Check84 days agoChange DetectedMinor update: version updated from v3.0.1 to v3.0.2; 'Back to Top' removed. No substantive changes to core content.SummaryDifference0.3%

Stay in the know with updates to Influenza Virus Challenge Trial for Monoclonal Antibody
Enter your email address, and we'll notify you when there's something new on the Influenza Virus Challenge Trial for Monoclonal Antibody page.